Abstract
Objective
To test the hypothesis that bone mineral density (BMD), a possible surrogate of lifetime exposure to hormone/growth factor/vitamin D/calcium exposure, is higher in prostate cancer cases than controls.
Methods
Hip BMD was measured by dual X-ray absorptiometry in 222 Afro-Caribbean screening-detected prostate cancer cases and 1,503 screened non-cases, aged 45–79, in the population-based Tobago Prostate Survey. Because possible skeletal metastases may modulate BMD, men with prostate specific antigen >20 ng/ml or highly undifferentiated tumors (Gleason score ≥8) were excluded. Mean BMD, adjusted for age and body mass index, was compared in cases and non-cases by analysis of variance. Risk across age group-specific BMD quartiles was compared using logistic regression.
Results
Overall, adjusted mean hip BMD was higher in cases (1.157 g/cm2) than non-cases (1.134 g/cm2) (p = 0.02). In men aged 60–79, prostate cancer risk was two-fold higher (OR, 2.12; 95% CI: 1.21–3.71) in the highest BMD quartile compared to the lowest. There was no association in younger men (interaction, p = 0.055).
Conclusions
High bone density is associated with prostate cancer among older men, consistent with an etiological role for lifetime exposure to factors which modulate bone density. However, other etiologies may dominate prostate cancer risk among younger men.
Similar content being viewed by others
Abbreviations
- BMD:
-
Bone mineral density
- BMI:
-
Body mass index
- IGFI:
-
Insulin-like growth factor I
- OR:
-
Odds ratio
- PSA:
-
Prostate specific antigen
- ANOVA:
-
Analysis of variance
- NHANES:
-
National Health and Nutrition Examination Survey
- SD:
-
Standard deviation
- CI:
-
Confidence interval
References
Ries LAG, Eisner MP, Kosary CL, et al (eds) (2005) SEER Cancer Statistics Review, 1975–2002, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2002/, based on November 2004 SEER data submission, posted to the SEER web site 2005, Table XXII-2
Glover Jr FE, Coffey DS, Douglas LL, et al (1998) The epidemiology of prostate cancer in Jamaica. J Urol 159:1984–1987
CH Bunker AL Patrick BR Konety et al. (2002) ArticleTitleHigh prevalence of Screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Survey Cancer Epidemiol Biomark Prev 11 726–729
R Ross L Bernstein H Judd R Hanisch M Pike B Henderson (1986) ArticleTitleSerum testosterone levels in healthy young black and white men J Natl Cancer Inst 76 45–48 Occurrence Handle3455741 Occurrence Handle1:CAS:528:DyaL28Xmt1eqsQ%3D%3D
AH Wu AS Whittemore LN Kolonel et al. (1995) ArticleTitleSerum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada Cancer Epidemiol Biomark Prev 4 735–741 Occurrence Handle1:CAS:528:DyaK2MXpslWnt74%3D
EA Platz EB Rimm WC Willett PW Kantoff E Giovannucci (2000) ArticleTitleRacial variation in prostate cancer incidence in hormonal system markers among male health professionals J Natl Cancer Inst 92 2009–2017 Occurrence Handle11121463 Occurrence Handle1:STN:280:DC%2BD3M3ls1ymtg%3D%3D Occurrence Handle10.1093/jnci/92.24.2009
VR Panz BI Joffe I Spitz T Lindenberg A Farkas M Haffejee (2001) ArticleTitleTandem CAG repeats of the androgen receptor gene and prostate cancer risk in black and white men Endocrine 15 213–216 Occurrence Handle11720249 Occurrence Handle1:CAS:528:DC%2BD3MXotVSrtbg%3D Occurrence Handle10.1385/ENDO:15:2:213
O Sartor Q Zheng JA Eastham (1999) ArticleTitleAndrogen receptor gene CAG repeat length varies in a race-specific fashion in men without prostate cancer Urology 53 378–380 Occurrence Handle9933058 Occurrence Handle1:STN:280:DyaK1M7ivFygug%3D%3D Occurrence Handle10.1016/S0090-4295(98)00481-6
RA Kittles D Young S Weinrich et al. (2001) ArticleTitleExtent of linkage disequilibrium between the androgen receptor gene CAG and GCC repeats in human populations: implications for prostate cancer risk Hum Genet 109 253–261 Occurrence Handle11702204 Occurrence Handle1:CAS:528:DC%2BD3MXptVKqtrg%3D Occurrence Handle10.1007/s004390100576
CL Bennett DK Price S Kim et al. (2002) ArticleTitleRacial variation in CAG repeat lengths within the androgen receptor gene among prostate cancer patients of lower socioeconomic status J Clin Oncol 20 3599–3604 Occurrence Handle12202660 Occurrence Handle1:CAS:528:DC%2BD38XntVynsr0%3D Occurrence Handle10.1200/JCO.2002.11.085
NL Chamberlain ED Driver RL Miesfeld (1994) ArticleTitleThe length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function Nucl Acids Res 22 3181–3186 Occurrence Handle8065934 Occurrence Handle1:CAS:528:DyaK2cXlvFOns7o%3D
Q Wang TS Udayakumar TS Vasaitis AM Brodie JD Fondell (2004) ArticleTitleMechanistic relationship between androgen receptor polyglutamine tract truncation and androgen-dependent transcriptional hyperactivity in prostate cancer cells J Biol Chem 279 17319–17328 Occurrence Handle14966121 Occurrence Handle1:CAS:528:DC%2BD2cXjt1GnsLw%3D Occurrence Handle10.1074/jbc.M400970200
MA Albertelli A Scheller M Brogley DM Robins (2006) ArticleTitleReplacing the mouse androgen receptor with human alleles demonstrates glutamine tract length dependent effects on physiology and tumorigenesis in mice Mol Endocrinol 20 1248–1260 Occurrence Handle16601069 Occurrence Handle1:CAS:528:DC%2BD28XltlSrsLo%3D Occurrence Handle10.1210/me.2006-0021
JM Chan MJ Stampfer E Giovanucci et al. (1998) ArticleTitlePlasma insulin-like growth factor-I and prostate cancer risk: a prospective study Science 279 563–566 Occurrence Handle9438850 Occurrence Handle1:CAS:528:DyaK1cXotVOqsg%3D%3D Occurrence Handle10.1126/science.279.5350.563
P Stattin A Bylund S Rinaldi et al. (2000) ArticleTitlePlasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study J Nat Cancer Inst 92 1910–1917 Occurrence Handle11106682 Occurrence Handle1:CAS:528:DC%2BD3cXptVehu7k%3D Occurrence Handle10.1093/jnci/92.23.1910
A Wolk CS Mantzoros S-O Andersson et al. (1998) ArticleTitleInsulin-like growth factor 1 and prostate cancer risk: a population-based, case–control study J Nat Cancer Inst 90 911–915 Occurrence Handle9637140 Occurrence Handle1:CAS:528:DyaK1cXktFOqsLc%3D Occurrence Handle10.1093/jnci/90.12.911
R Shi HJ Berkel H Yu (2001) ArticleTitleInsulin-like growth factor-I and prostate cancer: a meta-analysis Br J Cancer 85 991–996 Occurrence Handle11592771 Occurrence Handle1:CAS:528:DC%2BD3MXot1Sktb8%3D Occurrence Handle10.1038/sj.bjc.6691961
JK Cruickshank AH Heald S Anderson et al. (2001) ArticleTitleEpidemiology of the insulin-like growth factor system in three ethnic groups Am J Epidemiol 54 504–513 Occurrence Handle10.1093/aje/154.6.504
JA Cauley FL Lucas LH Kuller MT Vogt WS Browner SR Cummings (1996) ArticleTitleBone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group JAMA 276 1404–1408 Occurrence Handle8892715 Occurrence Handle1:STN:280:ByiD2cjoslA%3D Occurrence Handle10.1001/jama.276.17.1404
Zmuda JM, Cauley JA, Ljung BM, Bauer DC, Cummings SR, Kuller LH. Study of Osteoporotic Fractures Research Group (2001) Bone mass and breast cancer risk in older women: differences by stage at diagnosis. J Nat Cancer Inst 93:930–936
CA Conover (2000) Insulin-like growth factors and the skeleton E Canalis (Eds) Skeletal growth factors Lippincott Williams & Wilkins Philadelphia USA 101–116
KM Wiren ES Orwoll (1999) Androgens and bone: basic aspects ES Orwoll (Eds) Osteoporosis in men: the effects of gender on skeletal health Academic Press San Diego, USA 211–245
CJ Rosen (2000) ArticleTitleIGF-I and osteoporosis Clin Lab Med 20 591–602 Occurrence Handle10986623 Occurrence Handle1:STN:280:DC%2BD3M%2FmsVSksA%3D%3D
AM Parfitt (1997) ArticleTitleGenetic effects on bone mass and turnover-relevance to black/white differences J Am Coll Nutr 16 325–333 Occurrence Handle9263181 Occurrence Handle1:STN:280:ByiH3cfms1Y%3D
Y Zhang DP Kiel RC Ellison et al. (2002) ArticleTitleBone mass and the risk of prostate cancer: The Framingham Study Am J Med 113 734–739 Occurrence Handle12517363 Occurrence Handle10.1016/S0002-9343(02)01382-7
JP Richie WJ Catalona FR Ahmann et al. (1993) ArticleTitleEffect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination Urology 42 365–374 Occurrence Handle7692657 Occurrence Handle1:STN:280:ByuD38rktlY%3D Occurrence Handle10.1016/0090-4295(93)90359-I
AC Looker HW Wahner WL Dunn et al. (1998) ArticleTitleUpdated data on proximal femur bone mineral levels of US adults Osteopor Internat 8 468–489 Occurrence Handle1:STN:280:DyaK1M%2FmslensA%3D%3D Occurrence Handle10.1007/s001980050093
J Cauley JM Zmuda A Patrick VW Wheeler D Hill C Bunker (2001) ArticleTitleTobago Bone Health Study: Epidemiologic Study of high bone mineral density on a population level J Bone Min Res 16 IssueIDSuppl 1 M357
Nelson RL, Turyk M, Kim J, Persky V (2002) Bone mineral density and the subsequent risk of cancer in the NHANES I follow-up cohort. BMC Cancer 2:22 (accessed 12 March 2004 at http://www.biomedcentral.com/1471-2407/2/22)
RL Wolf JM Zmuda KL Stone JA Cauley (2000) ArticleTitleUpdate on the epidemiology of osteoporosis Curr Rheumatol Rep 2 74–86 Occurrence Handle11123043 Occurrence Handle1:STN:280:DC%2BD3M7ktVWqsg%3D%3D
GA Greendale S Edelstein E Barrett-Connor (1997) ArticleTitleEndogenous sex steroids and bone mineral density in older women and men: The Rancho Bernardo Study J Bone Miner Res 12 1833–1843 Occurrence Handle9383688 Occurrence Handle1:CAS:528:DyaK2sXns1yjs78%3D Occurrence Handle10.1359/jbmr.1997.12.11.1833
MC Bosland (2000) ArticleTitleThe role of steroid hormones in prostate carcinogenesis J Natl Cancer Inst Monogr 27 39–66 Occurrence Handle10963619 Occurrence Handle1:CAS:528:DC%2BD3cXlvVSnt7g%3D
AW Hsing JKV Reichardt FZ Stanczyk (2002) ArticleTitleHormones and prostate cancer: current perspective and future directions Prostate 52 213–235 Occurrence Handle12111697 Occurrence Handle1:CAS:528:DC%2BD38XmsVWqtbk%3D Occurrence Handle10.1002/pros.10108
AW Hsing C Streamson Y-T Gao E Gentzchien L Chang FZ Stanczyk (2001) ArticleTitleSerum levels of insulin and leptin in relation to prostate cancer risk: a population-based case–control study in China J Natl Cancer Inst 93 783–789 Occurrence Handle11353789 Occurrence Handle1:CAS:528:DC%2BD3MXkt1OktLs%3D Occurrence Handle10.1093/jnci/93.10.783
RP Stolk PL Daele ParticleVan HA Pols et al. (1996) ArticleTitleHyperinsulinemia and bone mineral density in an elderly population: The Rotterdam Study.[erratum appears in Bone. 1996; 19: 566] Bone 18 545–549 Occurrence Handle8805995 Occurrence Handle1:STN:280:BymA1Mblt1A%3D Occurrence Handle10.1016/8756-3282(96)00079-8
DM Peehl TA Stamey (1986) ArticleTitleSerum-free growth of adult human prostatic epithelial cells In Vitro Cell Dev Biol 22 82–90 Occurrence Handle2419302 Occurrence Handle1:STN:280:BimC3sbmvVE%3D
JA Cauley JM Zmuda AB Newman et al. (2003) ArticleTitleCirculating levels of soluble cytokine receptors predict incident fractures in older men and women: The Health Aging and Body Composition Study (HABC) J Bone Miner Res 18 IssueIDSuppl 2 S84
M Kawada M Ishizuka T Takeuchi (1999) ArticleTitleEnhancement of antiproliferative effects of interleukin-1beta and tumor necrosis factor-alpha on human prostate cancer LNCaP cells by coculture with normal fibroblasts through secreted interleukin-6 Jpn J Cancer Res 90 546–554 Occurrence Handle10391095 Occurrence Handle1:CAS:528:DyaK1MXjsVOmu7g%3D
Y Nakajima A DelliPizzi C Mallouh N Ferreri (1995) ArticleTitleEffect of tumor necrosis factor-alpha and interferon-gamma on the growth of human prostate cancer cell lines Urol Res 23 205–210 Occurrence Handle8533204 Occurrence Handle1:STN:280:BymD1M%2FotV0%3D Occurrence Handle10.1007/BF00393299
OW Rokhlin AV Gudkov S Kwek RA Glover AS Gewies MB Cohen (2000) ArticleTitlep53 is involved in tumor necrosis factor-alpha-induced apoptosis in the human prostatic carcinoma cell line LNCaP Oncogene 19 1959–1968 Occurrence Handle10773886 Occurrence Handle1:CAS:528:DC%2BD3cXjtV2qu7g%3D Occurrence Handle10.1038/sj.onc.1203453
ES Orwoll L Bevan KR Phipps (2000) ArticleTitleDeterminants of bone mineral density in older men Osteopor Internat 11 815–821 Occurrence Handle1:STN:280:DC%2BD3M7isV2nsA%3D%3D Occurrence Handle10.1007/s001980070039
AM Nomura (2001) ArticleTitleBody size and prostate cancer Epidemiol Rev 23 126–131 Occurrence Handle11588836 Occurrence Handle1:STN:280:DC%2BD3Mrkt1Sltg%3D%3D
Author information
Authors and Affiliations
Corresponding author
Additional information
The study was supported, in part, by funding or in-kind services from the Division of Health and Social Services, Tobago House of Assembly, the University of Pittsburgh Cancer Institute, the Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, contract DAMD 17-99-109015, U.S. Department of Defense, and grants R01 CA84950, R25-CA57703, U.S. National Cancer Institute, R01-AR049747, U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Rights and permissions
About this article
Cite this article
Bunker, C.H., Zmuda, J.M., Patrick, A.L. et al. High bone density is associated with prostate cancer in older Afro-Caribbean men: Tobago Prostate Survey. Cancer Causes Control 17, 1083–1089 (2006). https://doi.org/10.1007/s10552-006-0047-1
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10552-006-0047-1